In the developed world, vertebral osteomyelitis is most commonly acquired hematogenously. Staphylococcus aureus is the most frequent isolate, followed by streptococcus and gram-negative organisms. The lumbar spine is most commonly involved, but the thoracic spine may also be infected. The patient's progressive pain over a period of months is typical of vertebral osteomyelitis. Involvement of contiguous vertebral bodies and intervertebral disks is more suggestive of vertebral osteomyelitis than of malignant infiltration. Spinal epidural abscesses are caused by the same organisms and may result from hematogenous seeding of the epidural space or extension from vertebral osteomyelitis. For most patients who have vertebral osteomyelitis without epidural abscess, empirical antibiotic treatment can be delayed (but not by more than 24 hours) until biopsy is performed to obtain a microbiologic diagnosis; operative management is not required. In this case, however, the MRI and clinical findings are consistent with compression of the spinal cord by an epidural abscess; these findings mandate immediate neurosurgical consultation and mechanical decompression in an attempt to preserve neurologic function.
Less common causes of vertebral osteomyelitis and epidural abscess include Myco bacterium tuberculosis, fungi (e.g., Cryptococcus neoformans, candida species, Histoplasma capsulatum, and Coccidioides immitis), and brucella species. Spinal tuberculosis tends to involve the lower thoracolumbar spine and typically involves the anterior vertebral body. Arthritis, sacroiliitis, and spondylitis are the most common skeletal complications of brucella infection. Occasionally, spondylitis progresses to osteomyelitis and even abscess formation that may be difficult to distinguish from skeletal tuberculosis. The absence of granulomas on examination of the biopsy specimens and the absence of organisms identified with the use of special stains make these causes less likely but do not rule them out.
A purified protein derivative (PPD) test was positive, with 12 cm of induration. A chest radiograph did not show cavitary disease or other findings suggestive of pulmonary tuberculosis. On the basis of the clinical presentation and the results of the PPD test, a presumptive diagnosis of vertebral tuberculosis was made, and a regimen of ethambutol, isoniazid, pyrazinamide, and rifampin was started. Smears of three induced sputum specimens, obtained before therapy, were negative for acid-fast bacilli.
The patient then returned to the Philippines. There, despite reporting adherence to his antituberculosis regimen, he began to have high temperatures and drenching night sweats, and he lost 30 lb (14 kg). Seven months after his return to the Philippines, his relatives brought him back to the Baltimore hospital because of his difficulty with ambulation and new-onset fecal and urinary incontinence. He also had had a cough productive of bloody sputum for the previous 3 months.
Diagnosing skeletal tuberculosis is challenging. Cultures are positive in only half the cases; thus, empirical antituberculosis treatment is reasonable in patients with a positive PPD test, a compatible clinical presentation, and no other identified etiologic factors. However, granulomas are (Fig. 2) . Computed tomography (CT) of the chest confirmed this finding (Fig. 3) and also showed multiple smaller infiltrates throughout the right lung. CT and MRI of the spine revealed a large fluid collection behind the vertebral column, which was consistent with a paraspinal abscess (Fig. 4) . Analysis of the cerebrospinal fluid (CSF) showed 4 white cells per cubic millimeter, with normal glucose and protein levels. CSF was sent for Gram's staining and staining for acid-fast bacilli and fungi.
As suggested by the clinical findings, the patient has a large paraspinal abscess. Inflammatory markers are unhelpful in distinguishing one infectious cause from another. It is likely that the cavitary lung lesion was produced by the same organism that caused the paraspinal abscess. Tuberculosis usually involves the lung apex posteriorly; the anterior location in this case makes tuberculosis somewhat less likely. The patient requires surgical drainage, and specimens from both the lung lesion and the paraspinal abscess should be sent for bacterial, mycobacterial, and fungal cultures (with attention to culture of fastidious organisms). Assessment of specimens from both sources by polymerase chain reaction (PCR) for the presence of M. tuberculosis may be helpful.
The patient was admitted to the surgical service. A liter of purulent material was drained from his back and sent for Gram's staining, staining for acid-fast bacilli and fungi, and culture. The spinal hardware appeared to be stable, so it was left in place. His antituberculosis regimen was broadened to include moxifloxacin and amikacin in order to cover multidrug-resistant tuberculosis.
Empirical ceftriaxone therapy was started for a possible bacterial superinfection, and the patient was transferred to the medicine service.
Pending further culture data, the addition of two drugs for possible multidrug-resistant tuberculosis is reasonable; however, successful management is likely to require a definitive diagnosis, given the many possible etiologic factors. Bacterial pathogens that are difficult to grow on routine mediums remain a particular concern.
Multiple bacterial cultures from blood, induced sputum, CSF, and urine were negative. Staining of induced sputum, blood, and CSF for acid-fast bacilli and fungi was also negative. HIV testing was negative. In addition, none of the bacterial, mycobacterial, and fungal cultures obtained during the patient's first admission (including those from operative specimens) showed growth of any organisms. Gram's staining of material from the paraspinal abscess, however, revealed gram-negative bacilli, which later grew and were identified as oxidase-positive.
The gram-negative rods are likely to be either B. pseudomallei (causing melioidosis) or a brucella species. The patient may have had exposure to B. pseudomallei in Vietnam (since this bacterium can have a prolonged latency) or in the Philippines. A history of exposure to animals (e.g., cattle, sheep, or swine) or ingestion of unpasteurized milk products would increase the suspicion that the patient has brucellosis. B. pseudomallei is The clinical manifestations of melioidosis range from localized cutaneous abscesses to multiorgan involvement to septic shock. Symptoms develop in most patients within several weeks after exposure, but disease reactivation many years later has also been reported. Diabetes is a known risk factor, and this patient's vertebral osteomyelitis and cavitary pulmonary disease fit this diagnosis. If the organism cannot be definitively identified in the local microbiology laboratory, it should be sent to a reference facility. Serologic testing is available, but identification from culture provides the most definitive diagnosis. Ceftriaxone, although not standard therapy, is active against some strains of B. pseudomallei and may explain the clinical improvement in the patient's condition. Drainage of his abscess presumably also contributed to his improving neurologic status.
On the ninth hospital day, the organism was speciated by a reference laboratory as burkholderia. Antimicrobial-susceptibility studies showed sensitivity to carbapenems, trimethoprim-sulfamethoxazole, tetracyclines, ceftriaxone, and piperacillin-tazobactam. Antituberculosis therapy was discontinued, and treatment with intravenous meropenem and high-dose oral trimethoprimsulfamethoxazole was started. The organism was later identified by PCR at the Centers for Disease Control and Prevention (CDC) as B. pseudomallei, confirming the diagnosis of melioidosis. A chest CT obtained before the patient was discharged showed a reduction in the size of his lung cavity. After 2 weeks of intravenous antibiotics, longterm eradication therapy with oral doxycycline and trimethoprim-sulfamethoxazole was started. During an outpatient follow-up visit 3 months later, he reported feeling markedly improved; the erythrocyte sedimentation rate and the C-reactive protein had normalized.
Commenta r y
Melioidosis, caused by the gram-negative aerobic bacillus B. pseudomallei, is endemic to northern Australia and parts of Southeast Asia, including Vietnam and the Philippines. periodically as an adult; he also served in Vietnam as a young man. He may have acquired the infection in either place. B. pseudomallei is a freeliving natural inhabitant of soil and water, ubiquitous in rice-farming areas. Transmission occurs largely by means of percutaneous inoculation through exposed or abraded skin and also by inhalation or ingestion. It may also occur by means of aerosol in laboratory technicians who handle clinical specimens. 3 B. pseudomallei is listed by the CDC as a potential agent of biologic warfare. 4 The clinical presentation of melioidosis is diverse and includes acute and chronic, localized and systemic, subclinical and clinical disease. It is most commonly manifested as cavitary pneumonia, skin or soft-tissue infection, genitourinary infection, or sepsis. The pneumonia is often acquired by hematogenous spread but sometimes by inhalation. Cases of prostatic abscess, encephalitis, cerebral abscess, parotitis, hepatic abscess, splenic abscess, osteomyelitis, septic arthritis, and pericarditis have also been reported. 5 Risk factors for melioidosis include diabetes, renal disease, chronic lung disease, alcoholism, and other causes of immunosuppression. 6 HIV infection does not appear to be a risk factor for melioidosis. 7 Once acquired, B. pseudomallei can remain dormant for months or years, only to be reactivated when the immunity of the host is compromised. A latent period as long as 62 years has been reported. 8 The standard in diagnosing melioidosis is isolation of B. pseudomallei by culture from clinical specimens. Our patient had not been treated with antibiotics at the time of initial cultures, yet multiple specimens, including operative material from his first surgery, were negative despite the use of mediums that would have been expected to grow B. pseudomallei; the reason for this is unclear. PCR has been used increasingly to detect B. pseudomallei DNA directly from clinical specimens. 9 However, immunofluorescence microscopy is a more sensitive diagnostic tool and can be performed more rapidly. 10 In all cases, the laboratory should be specifically alerted if there is a clinical suspicion of melioidosis. This will also help protect microbiology staff from inadvertent exposure.
Melioidosis can be challenging to distinguish from tuberculosis both clinically and histologically. Chronic melioidosis may produce necrotizing granulomas that are indistinguishable from those of tuberculosis and should be considered especially when the presentation or course of a chronic infection is atypical for tuberculosis. In acute melioidosis, necrosis and abscess formation can serve as distinguishing features. Treatment of melioidosis requires a short course of "initiation" therapy followed by prolonged "eradication" therapy. According to a Cochrane metaanalysis, 11 intravenous ceftazidime, imipenem, or meropenem is an appropriate choice in the acute phase, and the selected antibiotic should be given for 14 days. As in the present case, tuberculosis is often the initial diagnosis that is considered in patients who present with signs of chronic infection involving the lungs and other systems, but melioidosis should also be routinely considered in patients with even a remote history of travel to regions in which the disease is endemic. A high clinical suspicion of B. pseudomallei in the appropriate circumstances will facilitate the identification of this organism and the protection of laboratory workers handling it.
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